Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
f0Ze6Uawc557Dnd6